Fee-Only Financial Advisor for Axon Employees in Arizona

Why Axon employees face an unusual planning problem

Most equity compensation planning deals with a stock that's performed reasonably, in line with the market. Axon's substantial share-price appreciation since going public has created a different situation for many long-tenured employees: positions worth many times their original grant value, often representing a large share of total household net worth. That's a good problem to have, but it's still a concentration problem — the kind that's easy to rationalize holding ("it's been such a good performer") right up until a downturn makes the cost of inaction clear.

What a fee-only advisor helps with

Systematic, tax-aware diversification. A multi-year plan for reducing concentration without triggering an unnecessarily large single-year tax bill.
Charitable giving strategy for highly appreciated shares, including donor-advised funds, for charitably inclined households looking to reduce concentrated gains tax-efficiently.
Options and vesting-schedule coordination for employees still receiving new equity grants alongside a large existing position.
Executive-level deferred compensation and 10b5-1 planning for senior employees and officers subject to trading windows and reporting requirements — see our broader guide on planning for corporate executives in Arizona.

How to find one

Browse the Scottsdale advisor directory and ask candidates directly about experience managing large, highly appreciated concentrated stock positions — this is a distinct skill from general financial planning.

Frequently asked questions

Why is concentration risk such a big issue for Axon employees specifically?

Axon's stock has appreciated substantially since its public listing, which means long-tenured employees and early equity recipients can end up with a position worth many multiples of its original grant value — often a large share of total household net worth concentrated in one company. That's exactly the situation where a diversification plan matters most, and exactly when it's hardest to act on emotionally, since selling means realizing a large taxable gain in a stock that's kept climbing.

Should I sell Axon stock even though it's been a strong performer?

Past performance doesn't reduce concentration risk going forward — a large single-stock position carries the same risk whether the stock has been a strong or weak performer historically. Most fee-only advisors recommend a systematic, tax-aware diversification plan rather than an all-at-once sale or an indefinite hold, tailored to your specific tax situation and goals.

What tax issues come up when diversifying a large, highly appreciated position?

Capital gains tax management across multiple years, coordinating sales with other income to manage tax-bracket impact, considering donor-advised fund gifting of appreciated shares for charitably inclined households, and for very large positions, sometimes exchange funds or other advanced strategies — all best evaluated by an advisor with no incentive to recommend one approach over another.

Is this page affiliated with Axon Enterprise?

No. Arizona Fee Only is an independent directory and is not affiliated with, sponsored by, or endorsed by Axon Enterprise. This page describes general planning considerations relevant to employees of high-growth, publicly traded companies based on publicly available information.

Does an advisor need to specialize in Axon specifically, or is general equity-comp experience enough?

General experience with concentrated stock, RSUs, and stock options is the more important qualification — the planning principles are similar across high-growth public companies. Ask directly about a candidate's experience managing large, highly appreciated single-stock positions specifically.